<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02223546</url>
  </required_header>
  <id_info>
    <org_study_id>CVdi</org_study_id>
    <nct_id>NCT02223546</nct_id>
  </id_info>
  <brief_title>Circadian Macular Volume Changes in the Choroid</brief_title>
  <acronym>CVdi</acronym>
  <official_title>Pilotstudy: Diurnal Changes in Choroidal Volume</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Choroidal volume measured fluctuates significantly over a 24 hour time frame.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients undergo enhanced depth imaging (EDI) by the Spectralis SD-OCT device (Heidelberg&#xD;
      Spectralis HRA2, Heidelberg Engineering, Heidelberg, Germany). SD-OCT measurements will be&#xD;
      performed in both eyes after pupil dilation.&#xD;
&#xD;
      Scanning Protocol: This studies choroidal volume measurement protocol has been previously&#xD;
      published. In short, 31 high resolution B-scans centered at the fovea will be obtained by a&#xD;
      single investigator. To optimize image quality each B-scan will be averaged from at least 25&#xD;
      individual scans using the build in eye tracking software (TrueTrack, Heidelberg Engineering,&#xD;
      Heidelberg, Germany). Scan length will be set to 9.3mm and spacing to 240Âµm, resulting in a&#xD;
      30x25 degree area around the fovea.&#xD;
&#xD;
      Each individual will undergo SD-OCT measurement every 3 hours within a 24 hour timeframe (at&#xD;
      0, 3, 6, 9 12, 15, 18, and 21 o'clock; 8 times total). Additionally, automated blood pressure&#xD;
      measurement and Goldmann applanation tonometry will be performed every 3 hours. Subject will&#xD;
      be instructed to sleep in erect position from 21 to 6 o'clock, and will be awoken for&#xD;
      examination at 0 and 3.&#xD;
&#xD;
      OCT Analysis: Two retinal specialists will manually adjust the segmentation lines for&#xD;
      automated choroidal volume calculation by the devices build in software. Choroidal thickness&#xD;
      is defined as the layer between the outer boarder of the retinal pigment epithelium (RPE) and&#xD;
      the hyper reflective layer behind the large vessels of the choroid (chorio-scleral&#xD;
      interface). The devices Software thus generates a three-dimensional choroidal thickness map,&#xD;
      divided according to the Early Treatment Diabetic Retinopathy Study (EDTRS) grid. In addition&#xD;
      to this, subfoveal choroidal thickness will be measured manually using the SD-OCTs integrated&#xD;
      caliper tool, drawing a perpendicular line to the RPE within the aforementioned bounds.&#xD;
&#xD;
      This is considered a pilot study, so explorative data analysis will be performed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Macular Choroidal Volume</measure>
    <time_frame>daily average out of measurements every 3 hours within a 24 hour timeframe</time_frame>
    <description>macular choroidal volume in the central 6mm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subfoveal Choroidal Thickness</measure>
    <time_frame>daily average out of measurements every 3 hours within a 24 hour timeframe</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Mean Ocular Perfusion Pressure</measure>
    <time_frame>every 3 hours within a 24 hour timeframe</time_frame>
    <description>mean arterial pressure (MAP) is defined as DBP + 1/3(SBP - DBP); mean ocular perfusion pressure results from 2/3(MAP - IOP).</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Choroid Physiology</condition>
  <arm_group>
    <arm_group_label>healthy subject</arm_group_label>
    <description>healthy subject, every 3 hour measurement</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Helathy human subjects&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-65, signed informed consent form,&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  any ocular pathology, including history of ocular surgery or trauma, use of ocular&#xD;
             medication, elevated intraocular pressure (IOP), or significant vitreous floaters.&#xD;
             Further exclusion criteria were current use of any systemic medications, history of&#xD;
             cardio-vascular disease, diabetes mellitus, or hypertension&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerald Seidel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Ophthalmology, Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/25447108</url>
    <description>PMID 25447108</description>
  </link>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 21, 2014</study_first_submitted>
  <study_first_submitted_qc>August 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2014</study_first_posted>
  <results_first_submitted>July 21, 2020</results_first_submitted>
  <results_first_submitted_qc>September 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 24, 2020</results_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Healthy Subject</title>
          <description>healthy subject, every 3 hour measurement</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Healthy Subject</title>
          <description>healthy subject, every 3 hour measurement</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Macular Choroidal Volume</title>
        <description>macular choroidal volume in the central 6mm</description>
        <time_frame>daily average out of measurements every 3 hours within a 24 hour timeframe</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Subject</title>
            <description>healthy subject, every 3 hour measurement</description>
          </group>
        </group_list>
        <measure>
          <title>Macular Choroidal Volume</title>
          <description>macular choroidal volume in the central 6mm</description>
          <units>mm^3</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.33" spread="2.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subfoveal Choroidal Thickness</title>
        <time_frame>daily average out of measurements every 3 hours within a 24 hour timeframe</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Subject</title>
            <description>healthy subject, every 3 hour measurement</description>
          </group>
        </group_list>
        <measure>
          <title>Subfoveal Choroidal Thickness</title>
          <units>Âµm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="378.1" spread="111.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Mean Ocular Perfusion Pressure</title>
        <description>mean arterial pressure (MAP) is defined as DBP + 1/3(SBP - DBP); mean ocular perfusion pressure results from 2/3(MAP - IOP).</description>
        <time_frame>every 3 hours within a 24 hour timeframe</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Healthy Subject</title>
          <description>healthy subject, every 3 hour measurement</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Gerald Seidel, MD</name_or_title>
      <organization>Medical University of Graz</organization>
      <phone>+43 316 385 12394</phone>
      <email>gerald.seidel@medunigraz.at</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

